Covetrus (NASDAQ: CVET)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.220 | 0.250 | 0.0300 | ||||
REV | 1.150B | 1.148B | -2.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Covetrus (NASDAQ: CVET) through any online brokerage.
Other companies in Covetrus’s space includes: AmerisourceBergen (NYSE:ABC), McKesson (NYSE:MCK), Henry Schein (NASDAQ:HSIC), Patterson Companies (NASDAQ:PDCO) and PetIQ (NASDAQ:PETQ).
The latest price target for Covetrus (NASDAQ: CVET) was reported by Stifel on Monday, June 13, 2022. The analyst firm set a price target for 22.00 expecting CVET to rise to within 12 months (a possible 6.18% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Covetrus (NASDAQ: CVET) is $20.72 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Covetrus.
Covetrus’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Covetrus.
Covetrus is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.